Brandywine Global Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-122,404
| Closed | -$76K | – | 722 |
|
|
2020
Q4 | $76K | Buy |
122,404
+1,801
| +1% | +$1.12K | ﹤0.01% | 619 |
|
|
2020
Q3 | $64K | Sell |
120,603
-4,700
| -4% | -$2.49K | ﹤0.01% | 585 |
|
|
2020
Q2 | $86K | Buy |
125,303
+1,900
| +2% | +$1.3K | ﹤0.01% | 632 |
|
|
2020
Q1 | $93K | Buy |
123,403
+708
| +0.6% | +$534 | ﹤0.01% | 644 |
|
|
2019
Q4 | $178K | Buy |
122,695
+27,495
| +29% | +$39.9K | ﹤0.01% | 656 |
|
|
2019
Q3 | $141K | Hold |
95,200
| – | – | ﹤0.01% | 660 |
|
|
2019
Q2 | $123K | Buy |
95,200
+31,029
| +48% | +$40.1K | ﹤0.01% | 669 |
|
|
2019
Q1 | $168K | Sell |
64,171
-9,445
| -13% | -$24.7K | ﹤0.01% | 647 |
|
|
2018
Q4 | $122K | Sell |
73,616
-11,220
| -13% | -$18.6K | ﹤0.01% | 664 |
|
|
2018
Q3 | $412K | Buy |
84,836
+172
| +0.2% | +$835 | ﹤0.01% | 597 |
|
|
2018
Q2 | $530K | Sell |
84,664
-2,020
| -2% | -$12.6K | ﹤0.01% | 611 |
|
|
2018
Q1 | $720K | Buy |
86,684
+69,157
| +395% | +$574K | ﹤0.01% | 596 |
|
|
2017
Q4 | $179K | Buy |
+17,527
| New | +$179K | ﹤0.01% | 707 |
|